Your browser doesn't support javascript.
loading
Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension.
Cavelier, Marine; Gondé, Henri; Costa, Damien; Lamoureux, Fabien; Pereira, Tony; Buchbinder, Nimrod; Varin, Rémi; Hervouët, Charles.
Afiliación
  • Cavelier M; CHU Rouen, Department of Pharmacy, F-76000 Rouen, France.
  • Gondé H; CHU Rouen, Department of Pharmacy, Normandie University, UNIROUEN, U1234, F-76000 Rouen, France.
  • Costa D; CHU Rouen, Department of Parasitology-Mycology, Normandie University, UNIROUEN, EA7510 ESCAPE, F-76000 Rouen, France.
  • Lamoureux F; CHU Rouen, Department of Pharmacology, F-76000 Rouen, France.
  • Pereira T; CHU Rouen, Department of Pharmacology, F-76000 Rouen, France.
  • Buchbinder N; CHU Rouen, Department of Pediatric Oncology and Hematology, F-76000 Rouen, France.
  • Varin R; CHU Rouen, Department of Pharmacy, Normandie University, UNIROUEN, U1234, F-76000 Rouen, France.
  • Hervouët C; CHU Rouen, Department of Pharmacy, F-76000 Rouen, France.
Pharmaceutics ; 15(2)2023 Jan 29.
Article en En | MEDLINE | ID: mdl-36839767
ABSTRACT
Nicardipine hydrochloride is an anti-hypertensive drug that is used off-label to treat hypertension in children. A previous oral formulation of nicardipine hydrochloride was developed using a commercial vehicle as an excipient. However, ready-to-use vehicles are prone to supply shortages, and their composition may undergo substantial modifications. The aim of this study was to propose a new oral formulation of nicardipine hydrochloride 2 mg/mL using simple excipients. The formulation included hydroxypropylmethylcellulose, simple syrup, polysorbate 80, sodium saccharin, citrate buffer, strawberry flavor and 0.2% potassium sorbate. The uniformity of content was maintained before and after agitation. Nicardipine hydrochloride concentration assessed by HPLC-MS/MS remained above 90% for 365 days before opening and for 28 days after opening. pH and osmolality were maintained throughout the study, and no microbial contamination was observed. The uniformity of mass of the delivered doses was evaluated using four different devices. A new oral formulation of nicardipine hydrochloride 2 mg/mL was developed using simple and safe excipients. Pharmacological and clinical parameters remain to be assessed and compared with those of the previous formulation.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: Francia